Immunosuppressive therapy in non-infections uveitis and retinovasculitis
Purpose: to evaluate the efficacy and safety of the immunosuppressive therapy for severe forms of non-infections uveitis and retinovasculitis.Methods: 107 patients (62 males and 45 females aged 9 to 54 years) who received low dose methotrexate — 7.5-20 mg once a week (n=79) cyclosporine A 3.5-5.0 mg...
Saved in:
Main Author: | E. A. Drozdova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2014-07-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/140 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19-associated retinovasculitis in the late stage of HIV infection: a clinical case
by: T. V. Gavrilova, et al.
Published: (2022-12-01) -
Evolution of Diagnostic Methods for Infectious and Non-Infectious Uveitis. Review
by: E. V. Boyko, et al.
Published: (2022-07-01) -
Adverse effects of immunosuppressive therapy after kidney transplant
by: S. V. Popov, et al.
Published: (2025-03-01) -
Failure of primary immunosuppressive agents in uveitis
by: Ankush Kawali, et al.
Published: (2025-06-01) -
Comparative effectiveness of various immunosuppressive therapy regimens for uveitis in patients with Behçet’s disease
by: T. A. Lisitsyna, et al.
Published: (2021-05-01)